A Canadian advisory panel recommends Vioxx to be returned to the market
They also want ibuprofen to be moved behind the counter so pharmacists can discuss with customers the risk of cardiovascular side effects.
A Canadian advisory panel recommends Vioxx to be returned to the market
Real physician voices, twice a week
Free, and one click to unsubscribe.
Keep reading
The Podcast
Latest episodes
Most popular
Hidden fees in employer health plans are about to come out
Bringing a newborn home? What hospitals don’t tell new parents
Is your clinical AI tool safe? 4 questions to ask first
Physician pay won’t budge for one doctor. Negotiate as a group.
Shy doctors can lead: imposter syndrome and the path to physician leadership
Clinical trials answer drug questions. Health questions need other tools.
Fired for seeing her own patients: moral injury and life after medicine
